Elanco Animal Health (XTER:5EA) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:5EA Elanco Animal Health Inc XTER:5EA
66 GF Score
Price €20.06
GF Value €12.44
! 5 Warning Signs
View Full Analysis

What is Elanco Animal Health Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XTER:5EA
66GF Score
Elanco Animal Health Inc XTER:5EA
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Elanco Animal Health (XTER:5EA) Overvalued in 2026?

Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued. The current stock price of €20.06 is trading 61.2% above its estimated GF Value™ of €12.44.

Key valuation signals for XTER:5EA:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €12.44 vs. price of €20.06 (61.2% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the XTER:5EA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elanco Animal Health Business Description

Other Exchanges ELAN:USA5EA:Germany
Address 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
66GF Score

Get the complete analysis for XTER:5EA

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.06
Price
€12.44
GF Value